Flagship Pioneering Unveils Quotient Therapeutics to Create Transformative Medicines Informed by a New Frontier of Genetics
https://reachmd.com/news/flagship-pioneering-unveils-quotient-therapeutics-to-create-transformative-medicines-informed-by-a-new-frontier-of-genetics/2453272/
Quotient's Somatic Genomics platform reveals new approaches to treat disease based on the vast genetic variation present in the body's trillions of cells Company emerges from stealth after two years of platform development with an initial commitment of $50 million from Flagship PioneeringCAM…
Vitamin B2 Derivatives Can Alleviate Chronic Kidney Inflammation, Research Suggests
https://reachmd.com/news/vitamin-b2-derivatives-can-alleviate-chronic-kidney-inflammation-research-suggests/2453293/
Immunofluorescence - staining of MAIT cells (green) next to mononuclear phagocytes (red) in kidney sections of mice with experimental glomerulonephritis. Cell nuclei in blue. Credit: Nature Communications (2023). DOI: 10.1038/…
Potential Therapeutic Target Found to Combat Tuberculosis, a Disrupted NAD(H) Homeostasis
https://reachmd.com/news/potential-therapeutic-target-found-to-combat-tuberculosis-a-disrupted-nadh-homeostasis/2453262/
Tuberculosis, the world’s leading infectious disease killer, caused 1.6 million deaths in 2021, along with 10 million new cases of tuberculosis every year. Tuberculosis, the world’s leading infectious disease killer, caused 1.6 million deaths in 2021, along with 10 million…
Immunotherapy, Radiation Do Not Increase Necrosis in NSCLC Brain Tumors
https://reachmd.com/news/immunotherapy-radiation-do-not-increase-necrosis-in-nsclc-brain-tumors/2456606/
Immunotherapy and radiation does not increase the risk of radiation necrosis for patients with non-small cell lung cancer who have brain metastases. Treatment with immunotherapy and radiation has been shown to not increase the risk of radiation necrosis for patients with non-small cell lung…
A Shift in Adjuvant Therapy: FDA Approves Nivolumab for Completely Resected Stage IIB/C Melanoma
https://reachmd.com/news/a-shift-in-adjuvant-therapy-fda-approves-nivolumab-for-completely-resected-stage-iibc-melanoma/2453267/
Metastatic subcutaneous melanomaImage courtesy of DermNetZTreatment for patients with melanoma is undergoing a paradigm shift. In October 2023, the FDA approved nivolumab (Opdivo; Bristol Myers Squibb) for patients 12 years and older with completely resected stage IIB/C melanoma.1 This recent appro…
Immunotherapy, Radiation Do Not Increase Necrosis in NSCLC Brain Tumors
https://reachmd.com/news/immunotherapy-radiation-do-not-increase-necrosis-in-nsclc-brain-tumors/2453266/
Immunotherapy and radiation does not increase the risk of radiation necrosis for patients with non-small cell lung cancer who have brain metastases. Treatment with immunotherapy and radiation has been shown to not increase the risk of radiation necrosis for patients with non-small cell lung…
Researchers Find Genetic Variants Linked to Uncommon, Deadly Illness
https://reachmd.com/news/researchers-find-genetic-variants-linked-to-uncommon-deadly-illness/2453277/
To make matters worse, most diseases have unknown genetic origins. Genetic variants are the source of many illnesses. A recent study published in the Journal of Clinical Immunology has provided light on the particular alterations causing a rare and fatal ailment called 'RAD50 deficiency/Nijmeg…
Study Finds People with Inflammatory Arthritis Face Significant Psychological Challenges in Maintaining Employment
https://reachmd.com/news/study-finds-people-with-inflammatory-arthritis-face-significant-psychological-challenges-in-maintaining-employment/2453255/
Study finds people with inflammatory arthritis face significant psychological challenges in maintaining employment Study finds people with inflammatory arthritis face significant psychological challenges in maintaining employment According to a recent study, individu…
Miniature Device Offers Peace of Mind for Diabetics
https://reachmd.com/news/miniature-device-offers-peace-of-mind-for-diabetics/2453238/
Researchers are designing an injected glucose biosensor and a watch-type reader device.Texas A&M Engineering The first glucose self-monitoring system created in 1970 weighed three pounds, was initially designed only for physicians’ offices and needed a large drop of blood for…
FDA Grants Fast Track Designation to Investigational RNA Replacement Enzyme-Based Cancer Gene Therapy to Treat Glioblastoma
https://reachmd.com/news/fda-grants-fast-track-designation-to-investigational-rna-replacement-enzyme-based-cancer-gene-therapy-to-treat-glioblastoma/2453233/
RZ-001 (Rznomics; Yongin-si, South Korea), a candidate RNA replacement enzyme-based cancer gene therapy, has been granted Fast Track Designation by the Food and Drug Administration (FDA) for investigation as a potential treatment for patients with glioblastoma (GBM). RZ-001 is desi…